A detailed history of Envestnet Asset Management Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 199,172 shares of CDXS stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,172
Previous 216,286 7.91%
Holding current value
$1.02 Million
Previous $670,000 8.51%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$2.62 - $3.71 $44,838 - $63,492
-17,114 Reduced 7.91%
199,172 $613,000
Q2 2024

Aug 08, 2024

BUY
$2.65 - $3.92 $144,788 - $214,177
54,637 Added 33.8%
216,286 $670,000
Q1 2024

May 13, 2024

BUY
$2.59 - $4.65 $108,487 - $194,774
41,887 Added 34.98%
161,649 $564,000
Q4 2023

Feb 13, 2024

BUY
$1.54 - $3.37 $126,001 - $275,730
81,819 Added 215.64%
119,762 $365,000
Q3 2023

Nov 13, 2023

SELL
$1.5 - $3.75 $15,033 - $37,582
-10,022 Reduced 20.89%
37,943 $71,000
Q2 2023

Aug 04, 2023

BUY
$2.21 - $4.43 $6,305 - $12,638
2,853 Added 6.32%
47,965 $134,000
Q1 2023

May 11, 2023

BUY
$3.81 - $6.76 $70,145 - $124,458
18,411 Added 68.95%
45,112 $186,000
Q4 2022

Feb 07, 2023

BUY
$4.26 - $6.84 $9,201 - $14,774
2,160 Added 8.8%
26,701 $124,000
Q3 2022

Nov 10, 2022

SELL
$6.06 - $12.86 $44,062 - $93,505
-7,271 Reduced 22.86%
24,541 $149,000
Q2 2022

Aug 03, 2022

BUY
$8.35 - $21.89 $36,339 - $95,265
4,352 Added 15.85%
31,812 $333,000
Q1 2022

May 04, 2022

SELL
$16.97 - $31.93 $67,472 - $126,953
-3,976 Reduced 12.65%
27,460 $566,000
Q4 2021

Feb 04, 2022

SELL
$25.61 - $41.78 $62,642 - $102,193
-2,446 Reduced 7.22%
31,436 $983,000
Q3 2021

Oct 07, 2021

BUY
$19.65 - $27.99 $349,259 - $497,494
17,774 Added 110.34%
33,882 $788,000
Q2 2021

Aug 04, 2021

BUY
$17.48 - $25.46 $36,305 - $52,880
2,077 Added 14.8%
16,108 $365,000
Q1 2021

May 04, 2021

BUY
$18.08 - $28.8 $17,736 - $28,252
981 Added 7.52%
14,031 $321,000
Q4 2020

Feb 02, 2021

BUY
$11.7 - $23.41 $11,395 - $22,801
974 Added 8.07%
13,050 $285,000
Q3 2020

Oct 09, 2020

SELL
$11.21 - $13.82 $5,896 - $7,269
-526 Reduced 4.17%
12,076 $142,000
Q2 2020

Jul 08, 2020

SELL
$9.8 - $12.77 $76,410 - $99,567
-7,797 Reduced 38.22%
12,602 $144,000
Q1 2020

Apr 23, 2020

BUY
$8.78 - $18.6 $18,675 - $39,562
2,127 Added 11.64%
20,399 $228,000
Q4 2019

Feb 11, 2020

BUY
$13.12 - $17.06 $37,287 - $48,484
2,842 Added 18.42%
18,272 $292,000
Q3 2019

Oct 17, 2019

BUY
$12.75 - $19.01 $15,210 - $22,678
1,193 Added 8.38%
15,430 $212,000
Q2 2019

Aug 02, 2019

BUY
$17.0 - $21.88 $242,029 - $311,505
14,237 New
14,237 $262,000
Q3 2018

Nov 14, 2018

SELL
$13.35 - $19.1 $29,690 - $42,478
-2,224 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$10.35 - $16.45 $1,914 - $3,043
185 Added 9.07%
2,224 $32,000
Q1 2018

May 09, 2018

BUY
$8.0 - $12.8 $3,016 - $4,825
377 Added 22.68%
2,039 $22,000
Q4 2017

Feb 20, 2018

BUY
$5.85 - $8.4 $6,271 - $9,004
1,072 Added 181.69%
1,662 $14,000
Q3 2017

Nov 13, 2017

BUY
$4.9 - $6.65 $2,891 - $3,923
590
590 $4,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.